YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Case Series: 11 Cases of Hemolytic Disease of the Fetus and Newborn Due To Kell Blood Group Incompatibility

dc.authorscopusid 57198437080
dc.authorscopusid 56705479600
dc.authorscopusid 26640178300
dc.authorscopusid 59394041900
dc.authorscopusid 56186063400
dc.contributor.author Yürektürk, E.
dc.contributor.author Aycan, N.
dc.contributor.author Başaranoğlu, M.
dc.contributor.author Arslan, B.
dc.contributor.author Tuncer, O.
dc.date.accessioned 2025-05-10T16:55:29Z
dc.date.available 2025-05-10T16:55:29Z
dc.date.issued 2024
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Yürektürk E., Neonatology Unit, Yüzüncü Yıl University, Van, Turkey; Aycan N., Neonatology Unit, Yüzüncü Yıl University, Van, Turkey; Başaranoğlu M., Neonatology Unit, Yüzüncü Yıl University, Van, Turkey; Arslan B., Department of Pediatric Hematology, Yüzüncü Yıl University, Van, Turkey; Tuncer O., Neonatology Unit, Yüzüncü Yıl University, Van, Turkey en_US
dc.description.abstract Hemolytic disease of the fetus and newborn (HDFN) results from the destruction of the newborn's red blood cells or the fetus by the mother's immune globulin G antibodies. Although HDFN is often caused by RhD and ABO incompatibility, it can also be seen due to minor blood groups such as Kell, Kidd, Duffy, P, MNS, or Rh subgroup (C, c, E, e) alloantibodies. Our study aims to share our experiences regarding a rare cause of HDFN. The files of patients who were followed up with the diagnosis of jaundice in a third-level Neonatology Unit of a university hospital between January 2014 and September 2023 were retrospectively examined. Eleven patients with Kell incompatibility were included in the study. There was no ABO/RhD incompatibility in any case. RhD subgroup incompatibility and Kell incompatibility were present in four cases. Phototherapy was applied to all patients. The patient, whose total bilirubin level was high despite phototherapy, was treated with an exchange transfusion. No complications were observed due to treatment or high total bilirubin. No significant difference was observed between the parameters evaluated according to the gender variable. It should be kept in mind that severe hemolysis and related deaths may occur due to Kell incompatibility. In order to reduce and prevent severe hemolysis due to Kell and other minor blood groups in newborns, transfusing blood products suitable for minor blood groups to women of childbearing age (especially pregnant women) may be a correct approach as a country policy. © 2024, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2024.55453
dc.identifier.endpage 466 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 4 en_US
dc.identifier.scopus 2-s2.0-85208128675
dc.identifier.scopusquality Q4
dc.identifier.startpage 462 en_US
dc.identifier.uri https://doi.org/10.5505/ejm.2024.55453
dc.identifier.uri https://hdl.handle.net/20.500.14720/3512
dc.identifier.volume 29 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Hdfn en_US
dc.subject Hemolytic Disease en_US
dc.subject Hyperbilirubinemia en_US
dc.subject Kell Incompatibility en_US
dc.title Case Series: 11 Cases of Hemolytic Disease of the Fetus and Newborn Due To Kell Blood Group Incompatibility en_US
dc.type Article en_US

Files